← Back to Search

N/A

E-Cigarettes' Respiratory Effects in Obese Youth (RESEC Trial)

N/A
Recruiting
Led By Dharini M Bhammar, PhD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 35 minutes
Awards & highlights

RESEC Trial Summary

This trial tests vaping behavior and lung health in youth who are obese and not obese who use e-cigarettes.

Who is the study for?
This trial is for young adults aged 21-25 who use e-cigarettes daily for at least the past three months. Participants must be willing to avoid all tobacco and nicotine for 12 hours before lab visits, attend five sessions up to four hours each, and can read and speak English.Check my eligibility
What is being tested?
The study aims to understand how using different types of e-cigarettes (ECIG own or ECIG Vuse) affects breathing in both obese and non-obese youth. It will involve observing vaping behaviors and measuring respiratory function.See study design
What are the potential side effects?
While specific side effects are not listed, using e-cigarettes can potentially impact lung function, cause throat irritation, coughing, or exacerbate pre-existing respiratory conditions.

RESEC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~35 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 35 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Airway resistance
Average Puff duration
Average Puff volume
+4 more
Secondary outcome measures
Exhaled carbon monoxide
Respiratory health questionnaire
Tiffany-Drobes Questionnaire of Smoking Urges

RESEC Trial Design

1Treatment groups
Experimental Treatment
Group I: VapingExperimental Treatment2 Interventions
All participants will undergo two vaping sessions: one using their own device and one using the study device

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor
320 Previous Clinical Trials
290,047 Total Patients Enrolled
Dharini M Bhammar, PhDPrincipal InvestigatorOhio State University
1 Previous Clinical Trials
78 Total Patients Enrolled

Media Library

ECIG own (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT05869318 — N/A
Electronic Cigarette Use Clinical Trial 2023: ECIG own Highlights & Side Effects. Trial Name: NCT05869318 — N/A
ECIG own (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05869318 — N/A
Electronic Cigarette Use Research Study Groups: Vaping

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings for me to join this medical experiment?

"Eligibility for this trial requires that participants are between the age of 21 and 25, with a history of electronic cigarette use. At present, 48 individuals need to be recruited."

Answered by AI

How many individuals have signed up for this experiment?

"Affirmative, clinicaltrials.gov hosts data that indicates this medical trial is actively recruiting participants. The study commenced on April 4th 2023 and was most recently updated May 19th of the same year. Exactly 48 patients are needed to be enrolled from a single site."

Answered by AI

Are volunteers being enlisted for this trial at the moment?

"Affirmative. Clinicaltrials.gov displays that this medical research, inaugurated on April 4th 2023, is currently searching for participants. Approximately 48 patients need to be recruited from 1 clinical setting."

Answered by AI

Is this study open to individuals under the age of 65?

"The study parameters stipulate that participants must be aged 21-25. For those outside of this range, there are 4 trials targeting minors and another 4 tailored to elderly patients."

Answered by AI
~32 spots leftby Dec 2026